Monopar Therapeutics Inc.
MNPR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,438 | -$2,454 | -$2,625 | -$10,926 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $279 |
| Change in WC | $248 | $97 | -$4,393 | $4,096 |
| Other Non-Cash | $1,099 | $1,280 | $1,355 | $4,552 |
| Operating Cash Flow | -$2,091 | -$1,077 | -$5,663 | -$1,998 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$5,726 | -$1,213 | -$1,926 | -$14,338 |
| Inv. Sales/Matur. | $3,600 | $2,400 | $1,600 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$2,126 | $1,187 | -$326 | -$14,338 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $127,773 | $5 | $15 | $56,204 |
| Stock Repurch. | -$35,000 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$382 | -$322 | -$131 | -$67 |
| Financing Cash Flow | $92,392 | -$317 | -$116 | $56,137 |
| Forex Effect | $0 | -$3 | -$0 | -$4 |
| Net Chg. in Cash | $88,175 | -$209 | -$6,105 | $39,796 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $39,502 | $39,711 | $45,816 | $6,020 |
| End Cash | $127,677 | $39,502 | $39,711 | $45,816 |
| Free Cash Flow | -$2,091 | -$1,077 | -$5,663 | -$1,998 |